The Board proposes that the Annual General Meeting resolves to authorise the Board to, on one or more occasions during the period up until the next Annual General Meeting, resolve to repurchase own shares on the following main terms and conditions. Acquisition of shares may be effected on Nasdaq Stockholm and in accordance with the Nasdaq Nordic Main Market Rulebook for Issuers of Shares. The maximum number of shares that may be repurchased is such that the company's holding of own shares at any time does not exceed 10 per cent of the total number of shares in the company. Repurchase of shares shall be made in accordance with the price limitations set out in the Nasdaq Nordic Main Market Rulebook for Issuers of Shares, which states that shares may not be purchased at a price higher than the higher of the price of the last independent trade and the highest current independent purchase bid on the trading venue where the purchase is carried out. Acquisition of shares on Nasdaq Stockholm may not be made at a price lower than the lowest price at which an independent purchase can be made. Payment for acquired shares shall be made in cash. The purpose of the authorisation is to allow the Board the opportunity to adjust the capital structure and thus create increased value for the company's shareholders.
App 18 Resolution on authorisation for the Board to resolve on acquisitions of own shares
Item 18: Resolution on authorisation for the Board to resolve on acquisitions of own shares
Earlier from Vitrolife Ab
- Vitrolife AB (publ) - Interim report Q1, 2026: Strong growth in Consumables and Technologies
- Invitation to Vitrolife Group's presentation of the Q1 2026 interim report

